Estimating sensitivity of laboratory testing for influenza in Canada through modelling.
BACKGROUND
The weekly proportion of laboratory tests that are positive for influenza is used in public health surveillance systems to identify periods of influenza activity. We aimed to estimate the sensitivity of influenza testing in Canada based on results of a national respiratory virus surveillance system.


RESULTS
The weekly number of influenza-negative tests from 1999 to 2006 was modelled as a function of laboratory-confirmed positive tests for influenza, respiratory syncytial virus (RSV), adenovirus and parainfluenza viruses, seasonality, and trend using Poisson regression. Sensitivity was calculated as the number of influenza positive tests divided by the number of influenza positive tests plus the model-estimated number of false negative tests. The sensitivity of influenza testing was estimated to be 33% (95%CI 32-34%), varying from 30-40% depending on the season and region.


CONCLUSIONS
The estimated sensitivity of influenza tests reported to this national laboratory surveillance system is considerably less than reported test characteristics for most laboratory tests. A number of factors may explain this difference, including sample quality and specimen procurement issues as well as test characteristics. Improved diagnosis would permit better estimation of the burden of influenza.
Schanzer
Dena L
DL
Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada. Dena_Schanzer@phac-aspc.gc.ca
Garner
Michael J
MJ
Hatchette
Todd F
TF
Langley
Joanne M
JM
Aziz
Samina
S
Tam
Theresa W S
TW
D002170:Canada / Q000453:epidemiology; D019411:Clinical Laboratory Techniques; D006801:Humans; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology*; D008962:Models, Theoretical; D012621:Seasons; D012680:Sensitivity and Specificity
Diagn Microbiol Infect Dis. 1986 Nov;5(4):307-12
3536275
Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S80-3
18820584
Clin Infect Dis. 2005 Sep 15;41(6):822-8
16107980
N Engl J Med. 2005 Dec 15;353(24):2559-67
16354892
J Clin Microbiol. 2003 Sep;41(9):4298-303
12958260
Euro Surveill. 2002 Dec;7(12):180-3
12631984
J Clin Microbiol. 2006 Jun;44(6):2265-7
16757636
Can J Public Health. 2009 May-Jun;100(3):204-7
19507723
J Clin Virol. 2007 Jun;39(2):132-5
17452000
J Infect. 2007 Sep;55(3):240-8
17582503
J Clin Virol. 2005 Jun;33(2):172-5
15911434
Influenza Other Respir Viruses. 2008 Jan;2(1):1-8
19453488
Pediatr Infect Dis J. 2006 Sep;25(9):795-800
16940836
Clin Microbiol Rev. 2006 Jan;19(1):165-256
16418529
Arch Intern Med. 2008 Dec 8;168(22):2489-96
19064834
J Clin Virol. 2004 Sep;31(1):40-5
15288612
J Clin Microbiol. 2007 Jul;45(7):2260-2
17507513
Clin Infect Dis. 2008 Apr 1;46(7):e61-4
18444806
J Clin Microbiol. 2002 Nov;40(11):4337-9
12409425
J Clin Microbiol. 2003 Oct;41(10):4642-6
14532196
J Obstet Gynaecol Can. 2007 Aug;29(8):622-9
17714614
Can Commun Dis Rep. 2007 Feb 1;33(3):21-41
17323533
Epidemiol Infect. 2007 Aug;135(6):951-8
17156502
Vaccine. 2008 Aug 26;26(36):4697-703
18620016
Clin Diagn Lab Immunol. 2005 Mar;12(3):367-70
15753248
Can Commun Dis Rep. 2005 Jan 1;31(1):1-18
15645607
Clin Infect Dis. 2007 Dec 15;45(12):1568-75
18190317
Pediatrics. 2007 Jan;119(1):e6-11
17200259
Epidemiol Infect. 2007 Oct;135(7):1109-16
17306052
CMAJ. 2002 Feb 19;166(4):445-6
11873921
JAMA. 2004 Sep 15;292(11):1333-40
15367555
J Clin Microbiol. 2003 Aug;41(8):3487-93
12904343
J Infect Dis. 2004 Feb 15;189(4):706-10
14767825
J Infect Dis. 2006 Nov 1;194 Suppl 2:S98-110
17163396
J Clin Microbiol. 2002 Jun;40(6):2051-6
12037063